Generation and characterization of C305, a murine neutralizing scFv antibody that can inhibit BLyS binding to its receptor BCMA

Acta Biochimica et Biophysica Sinica

Volumn 37, Issue 6, 2005, Pages 415-420

  Liu, Mei Yun ^a,b   Han, Wei ^b,c   Ding, Yan Li ^b,c   Zhou, Tian Hong ^a   Tian, Rui Yang ^b   Yang, Sheng Li ^b   Liu, Hui ^b   Gong, Yi ^b  

^a JINAN UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

BLyS; Neutralizing; Phage display; scFv antibody

Indexed keywords

ANTIBODY; B CELL ACTIVATING FACTOR; B CELL MATURATION ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MEMBRANE PROTEIN; PEPTIDE LIBRARY; TNFRSF17 PROTEIN, MOUSE; TNFSF13B PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CROSS REACTION; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY FORMATION; B-CELL ACTIVATING FACTOR; B-CELL MATURATION ANTIGEN; B-LYMPHOCYTES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MEMBRANE PROTEINS; MICE; PEPTIDE LIBRARY; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 24944463659     PISSN: 16729145     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2005.00059.x     Document Type: Article

References (18)

1. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D et al. BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999, 285: 260-263
2. Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, Cachero TG, Mackay F et al. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med 2000, 192: 129-136
3. Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, Dixit VM. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol 2000, 1: 37-41
4. Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol 2000, 10: 785-788
5. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000, 404: 995-999
6. Schneider P, Mackay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999, 189: 1747-1756
7. Shu HB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down regulated by mitogens. J Leukoc Biol 1999, 65: 680-683
8. Mukhopadhyay A, Ni J, Zhai Y, Yu GL, Aggarwal BB. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-κB, and c-Jun NH2-terminal kinase. J Biol Chem 1999, 274: 15978-15981
9. Tribouley C, Wallroth M, Chan V, Paliard X, Fang E, Lamson G, Pot D et al. Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem 1999, 380: 1443-1447
10. Kin HM, Yu KS, Lee ME, Shin DR, Kim YS, Paik SG, Yoo OJ et al. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation. Nat Struct Biol 2003, 10: 342-348
11. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestation. J Exp Med 1999, 190: 1697-1710
12. Khare SD, Sarosi I, Xia XZ, McCabe S, Miner K, Solovyev I, Hawkins N et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 2000, 97: 3370-3375
13. Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessier BJ, Bastion H et al. A role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 2001, 166: 6-10
14. Cheema GS, Roschke V, Hilbert DM, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 2001, 44: 1313-1319
15. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J et al. Association of BAFF/BlyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002, 109: 59-68
16. Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R. The level of BlyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann Rheum Dis 2003, 62: 168-171
17. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E et al. An essential role for BAFF in the normal development of B cell through a BCMA-independent pathway. Science 2001, 293: 2111-2114
18. Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune diseases: Impaired B cell maturation in mice lacking BLyS. Immunity 2001, 15: 289-302